Send us a text

You think going digital in pathology just means buying a scanner?

Think again.

In this episode sponsored by Epredia, I sat down with Ryan Davis, Director of Global Business Strategy at Epredia, to talk about what it really takes to implement digital pathology—and why modularity, cytology support, and AI integration are changing the game.

Whether you’re starting your digital journey or scaling up with advanced tech, there’s something in this conversation for you.

🎯 Highlights with Timestamps:

• [00:01:00] Who is Ryan Davis? Epredia’s digital transformation story
• [00:04:00] From Thermo Fisher to PHC Group: A legacy of diagnostic solutions
• [00:06:00] The 3DHistech partnership—why collaboration > competition
• [00:10:00] Spotlight: The P1000 scanner and its water immersion feature
• [00:16:00] Modular, fluorescent, and multi-functional scanners explained
• [00:21:00] Interoperability: Integrating with existing AI and IMS systems
• [00:24:00] Global footprint and customer feedback (Radboud, CorePlus, Puerto Rico)
• [00:27:00] Use cases in biopharma and neuroscience
• [00:30:00] AI partners: Aiforia, PaigeAI, IBEX, TechCyte
• [00:34:00] What’s coming: FDA clearance, polarization scanners
• [00:38:00] Community outreach through DPA and global conferences
• [00:40:00] Learn more: Live Labs and webinars at www.epredia.com
  
  
  

📚 Resources from this Episode:

• CorePlus Study: Deployment of Artificial Intelligence Algorithm for 100% QC of Pap Tests
• Epredia Live Labs: www.epredia.com → Events
• AI partners mentioned: Aiforia, PaigeAI, TechCyte, IBEX
  
  

Support the show

Become a Digital Pathology Trailblazer get the "Digital Pathology 101" FREE E-book and join us!

Send us a text

In this episode, I talk with Tiffany Chen, MD, and Ben Cahoon from Techcyte about Fusion, their new digital pathology platform. Fusion integrates clinical and anatomic pathology workflows, AI algorithms, and electronic health records—all into one streamlined experience.

We explore how Fusion simplifies case management, improves diagnostic accuracy, and brings AI-powered pathology into routine practice. Plus, we discuss the importance of open standards, partnerships with Mayo Clinic, and why flexible integration is key for healthcare innovation.

If you’re passionate about digital pathology, AI, and advancing patient care, this is a conversation you don’t want to miss!

✨ Key Highlights
- Introduction of Techcyte’s Fusion platform: bridging clinical and anatomic pathology workflows
- How Fusion integrates AI, EHRs, and LIS systems using open standards (FHIR, DICOM, HL7)
- Collaborations with Mayo Clinic and BD for scalable global deployment
- AI marketplace support: Fusion enables the integration of internal, partner, and institutional AI models
- Impact of AI on cytology workflows and pathology screening
- Flexibility for lab-driven or PACS-driven workflows
- Future plans: Subspecialty-focused AI enhancements and smart synoptic reporting integration
- The importance of interoperability and data standardization for healthcare AI

This Episode's Resources:

Techcyte Fusion Platform: https://techcyte.com/fusion/

Support the show

Become a Digital Pathology Trailblazer get the "Digital Pathology 101" FREE E-book and join us!

Send us a text

Why do so many digital pathology tools stall before they ever reach patients?

In this USCAP 2025 special sponsored by Muse Microscopy, I talk with Esther Abels, founder of SolarisRTC, regulatory strategist, and the force behind the first FDA-cleared whole slide imaging system.

We break down what startups and established companies must do from day one to succeedbin getting their devices through the FDA. Hint: regulatory strategy isn’t a final step—it’s your starting line.

🧠 What You’ll Learn:

• [00:01:00] Why regulatory planning must start at inception
• [00:03:00] How Esther helped Philips get the first scanner FDA cleared
• [00:05:00] Clinical study design, documentation, and risk strategy
• [00:08:00] Timeline expectations for clearance and review
• [00:10:00] The role of consultants vs. internal regulatory teams
• [00:13:00] Using meta-analysis, synthetic data, and publications
• [00:15:00] How the DPA is driving system decoupling & AI regulatory clarity
  
  

🎧 Tune in to learn how to build compliance into innovation—from tissue imaging to AI-powered diagnostics.

#DigitalPathology #RegulatoryStrategy #FDAApproval #ClinicalInnovation #PathologyTools #MUSEmiscroscopy #sponsored #USCAP2025

Support the show

Become a Digital Pathology Trailblazer get the "Digital Pathology 101" FREE E-book and join us!